首页|普拉洛芬滴眼液控制白内障术后炎症的价值及不良反应观察

普拉洛芬滴眼液控制白内障术后炎症的价值及不良反应观察

扫码查看
目的 观察白内障术后炎症患者接受普拉洛芬滴眼液治疗的应用价值以及对其不良反应的影响.方法 98 例白内障术后炎症患者,取奇偶分组法分为对照组与观察组,每组 49 例.对照组采用氟米龙滴眼液治疗,观察组采用普拉洛芬滴眼液治疗.对比两组治疗前后的炎症因子[C反应蛋白(CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]水平、眼压、视力、黄斑中心凹厚度,治疗后眼部症状积分,临床疗效,不良反应发生率.结果 治疗后,两组的IL-6、TNF-α、CRP水平均较治疗前降低,且观察组的IL-6(84.36±8.26)ng/L、TNF-α(1.06±0.08)ng/L、CRP(8.51±0.63)mg/L明显低于对照组的(92.38±9.05)ng/L、(1.57±0.13)ng/L、(10.36±0.85)mg/L(P<0.05).治疗后,两组的眼压均较治疗前明显降低,视力和黄斑中心凹厚度均较治疗前明显升高,且观察组的眼压(14.08±1.22)mm Hg(1 mm Hg=0.133 kPa)明显低于对照组的(16.77±1.45)mm Hg,视力(0.81±0.07)和黄斑中心凹厚度(191.34±17.28)μm明显高于对照组的(0.54±0.04)、(179.35±16.94)μm(P<0.05).观察组治疗后的畏光、异物感、溢泪、疼痛积分分别为(0.36±0.03)、(0.32±0.02)、(0.31±0.02)、(0.12±0.01)分,明显低于对照组(0.52±0.04)、(0.49±0.03)、(0.47±0.03)、(0.31±0.02)分(P<0.05).观察组的临床总有效率 95.92%高于对照组的 79.59%(P<0.05).观察组治疗期间的不良反应发生率 6.12%明显低于对照组的24.49%(P<0.05).结论 白内障术后炎症患者接受普拉洛芬滴眼液治疗,可以有效降低炎性因子以及眼压水平,视力得到显著提升,患者的各项症状积分明显改善,具有较好的治疗效果,且不良反应较少.
Observation on value and adverse reactions of pranoprofen eye drops in controlling inflammation after cataract surgery
Objective To observe the application value of pranoprofen eye drops in patients with inflammation after cataract surgery and its influence on the adverse reactions.Methods 98 patients with inflammation after cataract surgery were divided into a control group and an observation group by odd-even grouping method,with 49 cases in each group.The control group was treated with fluorometholone eye drops,and the observation group was treated with pranoprofen eye drops.Both groups were compared in terms of levels of inflammatory markers[C-reactive protein(CRP),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)],intraocular pressure,visual acuity and macular fovea thickness before and after treatment,ocular symptom score after treatment,clinical efficacy and incidence of adverse reactions.Results After treatment,the levels of IL-6,TNF-α and CRP in both groups were lower than those before treatment;the observation group had IL-6 of(84.36±8.26)ng/L,TNF-α of(1.06±0.08)ng/L and CRP of(8.51±0.63)mg/L,which were significantly lower than(92.38±9.05)ng/L,(1.57±0.13)ng/L and(10.36±0.85)mg/L in the control group(P<0.05).After treatment,the intraocular pressure in both groups was significantly lower than that before treatment,and the visual acuity and macular fovea thickness were significantly higher than those before treatment;the intraocular pressure of(14.08±1.22)mm Hg(1 mm Hg= 0.133 kPa)in the observation group was significantly lower than(16.77±1.45)mm Hg in the control group;the visual acuity of(0.81±0.07)and macular fovea thickness of(191.34±17.28)μm in the observation group were significantly higher than(0.54±0.04)and(179.35±16.94)μm in the control group(P<0.05).After treatment,the scores of photophobia,foreign body sensation,tears and pain in the observation group were(0.36±0.03),(0.32±0.02),(0.31±0.02)and(0.12±0.01)points,which were significantly lower than(0.52±0.04),(0.49±0.03),(0.47±0.03)and(0.31±0.02)points in the control group(P<0.05).The total clinical effective rate of 95.92%in the observation group was higher than 79.59%in the control group(P<0.05).The incidence of adverse reactions during treatment in the observation group was 6.12%,which was significantly lower than 24.49%in the control group(P<0.05).Conclusion For patients with inflammation after cataract surgery,pranoprofen eye drops can effectively reduce the level of inflammatory markers and intraocular pressure,significantly improve visual acuity,and significantly improve the score of various symptoms of patients,which has a better therapeutic effect and fewer adverse reactions.

CataractPostoperative inflammationPranoprofen eye dropsAdverse reactionsClinical efficacy

胡秀丽

展开 >

222000 连云港市眼科医院

白内障 术后炎症 普拉洛芬滴眼液 不良反应 临床疗效

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(5)
  • 12